Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


CVS HEALTH CORP   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2022202120202019201820172016201520142013
Period End Date12/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/2013
Products226,616.00203,738.00190,688.00185,236.00183,910.00180,063.00173,377.00------
Revenues--------------153,290.00139,367.00126,761.00
Premiums85,330.0076,132.0069,364.0063,122.008,184.003,558.003,069.00------
Services9,683.0011,042.007,856.007,407.001,825.001,144.001,080.00------
Net investment income838.001,199.00798.001,011.00660.0021.0020.00------
Total Revenues322,467.00292,111.00268,706.00256,776.00194,579.00184,786.00177,546.00153,290.00139,367.00126,761.00
Cost of revenues196,892.00175,803.00163,981.00158,719.00156,447.00153,448.00146,533.00126,762.00114,000.00102,978.00
Gross Profit------98,057.0038,132.0031,338.0031,013.0026,528.0025,367.0023,783.00
Depreciation and amortization--------------------
Goodwill impairments--431.00----6,149.00181.000.00------
Selling, general and administrative expenses--------------------
Loss on assets held for sale(2,533.00)------------------
Operating income (expenses)(38,212.00)(37,066.00)(35,135.00)(33,310.00)(21,368.00)(18,809.00)(18,448.00)(17,053.00)(16,568.00)(15,746.00)
Benefit costs(71,281.00)(64,260.00)(55,679.00)(52,529.00)(6,594.00)(2,810.00)(2,179.00)------
Store impairments--(1,358.00)--(231.00)------------
Opioid litigation charges(5,803.00)------------------
Total operating costs314,721.00278,918.00254,795.00244,789.00190,558.00175,248.00167,160.00------
Operating Income (Loss)7,746.0013,193.0013,911.0011,987.004,021.009,538.0010,386.009,475.008,799.008,037.00
Interest expense, net2,287.002,503.002,907.003,035.002,619.001,062.001,078.00838.00600.00509.00
Loss on early extinguishment of debt--(452.00)(1,440.00)(79.00)0.000.00(643.00)0.00(521.00)0.00
Other expense169.00182.00206.00124.004.00(208.00)(28.00)(21.00)----
Income before income tax provision5,628.0010,420.009,770.008,997.001,406.008,268.008,637.008,616.007,678.007,528.00
Current: Federal2,803.002,285.002,615.002,450.001,480.002,594.002,803.003,065.002,581.002,623.00
Current: State735.00665.00518.00565.00499.00464.00511.00555.00495.00437.00
Income tax (benefit) provision1,463.002,522.002,569.002,366.002,002.001,637.003,317.003,386.003,033.002,928.00
Deferred: Federal(1,569.00)(306.00)(450.00)(535.00)22.00(1,435.00)5.00(180.00)(43.00)(115.00)
Deferred: State(506.00)(122.00)(114.00)(114.00)1.0014.00(2.00)(54.00)0.00(17.00)
Income (loss) from Continuing Operations4,165.007,898.007,201.006,631.00(596.00)6,631.005,320.005,230.004,645.004,600.00
Income (Loss) from discontinued operations, net of tax benefit----(9.00)0.000.00(8.00)(1.00)9.00(1.00)(8.00)
Consolidated Net Income (Loss)4,165.007,898.007,192.006,631.00(596.00)6,623.005,319.005,239.004,644.004,592.00
Net loss attributable to noncontrolling interest16.00(12.00)13.00(3.00)(2.00)1.002.002.000.000.00
Preference dividends, net of income tax benefit--------------------
Net Income (Loss) Available to Common Shareholders4,149.007,910.007,179.006,634.00(594.00)6,622.005,317.005,237.004,644.004,592.00
Net earnings available to common shareholders, diluted--------------------
Earnings from continuing operations (BASIC)3.166.005.495.10(0.57)6.484.934.653.983.78
EPS (Basic) : Income (loss) from Discontinued operations----(0.01)----(0.01)0.000.010.00(0.01)
Net Earnings Per Share (Basic)3.166.005.485.10(0.57)6.474.934.663.983.77
Earnings from continuing operations (DILUTED)3.145.955.475.08(0.57)6.454.914.623.963.75
EPS (Diluted) : Income (loss) from Discontinued operations----(0.01)----(0.01)0.000.010.00(0.01)
Net Earnings Per Share (Diluted)3.145.955.465.08(0.57)6.444.904.633.963.74
Weighted Average Shares Outstanding (Basic)1,312.001,319.001,309.001,301.001,044.001,020.001,073.001,118.001,161.001,217.00
Weighted Average Shares Outstanding (Diluted)1,323.001,329.001,314.001,305.001,044.001,024.001,079.001,126.001,169.001,226.00